Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.33 |
| ▸ | PI4KA | P42356 | 2/20 | 0.31 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.31 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.31 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5720237 | 0.82 | LRRK2 (0.31) | DYRK1API4KAPI4K2BPI4K2API4KB | |
| SCHEMBL2934090 | 0.82 | PARP1 (0.34) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| SCHEMBL130108 | 0.82 | HPGD (0.39) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| SCHEMBL19618145 | 0.80 | HPGD (0.31) | — | |
| SCHEMBL6745188 | 0.79 | HPGD (0.30) | — | |
| SCHEMBL18879374 | 0.76 | HTT (0.31) | — | |
| SCHEMBL19261349 | 0.76 | HTT (0.31) | — | |
| SCHEMBL13014 | 0.74 | CSNK2A2 (0.40) | MEN1CSNK2A2RAB9ACSNK2BCSNK2A1 | |
| SCHEMBL31139534 | 0.74 | CSNK2A2 (0.40) | MEN1CSNK2A2RAB9ACSNK2BCSNK2A1 | |
| SCHEMBL19618124 | 0.73 | HTT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612548-B2 | Method for producing inorganic fluoride luminescent material | NICHIA CORPORATION (JP) | 2026-04-28 | — | — | US | disclosed |
| US-20230220275-A1 | METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL | NICHIA CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230142294-A1 | PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL | NICHIA CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| WO-2021241375-A1 | PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL | 日亜化学工業株式会社 | 2021-12-02 | — | — | WO | disclosed |
| WO-2021241376-A1 | METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL | 日亜化学工業株式会社 | 2021-12-02 | — | — | WO | disclosed |
| EP-1072576-B1 | FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2006-08-02 | — | — | EP | disclosed |
| US-6417361-B1 | HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2002-07-09 | — | — | US | disclosed |
| EP-1072576-A1 | FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2001-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612548-B2 | Method for producing inorganic fluoride luminescent material | FLNA, F7, NPM1 | MEN1 680/4885CSNK2A2 2707/4885RAB9A 591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.